Abiopharma

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results

Werewolf Therapeutics to Participate in HansonWade’s 6th Annual Cytokine-Based Drug Development Summit

Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

CoyaTherapeutics - Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001“Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Charles River Laboratories to Present at Bank of America Health Care Conference